IceCure Medical Reports First Quarter 2025 Financial Results
Provided By PR Newswire
Last update: May 28, 2025
Recently finalized and delivered proposed post market study plan to the FDA; Awaiting marketing authorization decision for ProSense® in women aged 70+ with early-stage low risk breast cancer
Read more at prnewswire.com
